You can upload your final appeal letter and any supporting documents, including medical records or test results
Researchers should note that some immortalized cell lines (particularly HEK293) express relatively low IGF-1R and may require receptor overexpression constructs to achieve meaningful signaling responses
Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, offering a promising adjunct to traditional treatments
The absence of serious adverse events, treatment-related withdrawals, IGF-1 elevation, glucose metabolism impairment, or immunogenic responses represents a favorable safety foundation
Analysis of FDA adverse event data from 2003 to 2024 found only 182 cases of male sexual dysfunction among millions of GLP-1 users
Beyond CGRP: the calcitonin peptide family as targets for migraine and pain